Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease

Published:2021-03-14 Issue:10 Volume:27 Page:959-975
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Nadinskaia Maria,Maevskaya Marina,Ivashkin Vladimir,Kodzoeva Khava,Pirogova Irina,Chesnokov Evgeny,Nersesov Alexander,Kaibullayeva Jamilya,Konysbekova Akzhan,Raissova Aigul,Khamrabaeva Feruza,Zueva Elena

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference66 articles.

1. OPTN/SRTR 2018 Annual Data Report: Liver

2. Nonalcoholic Fatty Liver Disease

3. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

4. Ivashkin VT, Drapkina OM, Mayev IV, Trukhmanov AS, Blinov DV, Palgova LK, Tsukanov VV, Ushakova TI. Prevalence of nonalcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results. (In Russian). Ross z Gastroenterol Gepatol Koloproktol 2015; 6: 31-41

5. Epidemiological Investigation of Fatty Liver Disease and Abnormal Liver Function in the Republic of Kazakhstan

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of intestinal flora in nonobese nonalcoholic fatty liver disease patients and the impact of ursodeoxycholic acid treatment on these features;Lipids;2024-09-09

2. Risk of hepatic steatosis with the preoperative treatment of pancreatic cancer and the short-term postoperative outcomes;Surgery Today;2024-07-09

3. Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis;Clinical Nutrition;2024-06

4. The role of gut microbiota associated metabolites in digestive disorders;Engineered Regeneration;2024-06

5. Ursodeoxycholic and chenodeoxycholic bile acids attenuate systemic and liver inflammation induced by lipopolysaccharide in rats;Molecular and Cellular Biochemistry;2024-04-05